Immunohistochemistry (IHC) results from HPA demonstrated that DLGAP5 protein was found to be strongly expressed in BC tumor tissues, while SLC16A6, CAB39L, and HBA demonstrated lower protein expression in BC tissues (Figure 11B). This evidence concerns the gene DLGAP5 and breast cancer.